Latest Insider Transactions at Morphic Holding, Inc. (MORF)
This section provides a real-time view of insider transactions for Morphic Holding, Inc. (MORF). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Morphic Holding, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Morphic Holding, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2022
|
Bruce Rogers PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
9,600
+7.84%
|
$38,400
$4.32 P/Share
|
|
Apr 01
2022
|
Bruce Rogers PRESIDENT |
SELL
Open market or private sale
|
Direct |
10,000
-4.51%
|
$410,000
$41.15 P/Share
|
|
Apr 01
2022
|
Bruce Rogers PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.14%
|
$40,000
$4.32 P/Share
|
|
Dec 29
2021
|
William De Vaul General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
17,452
+44.62%
|
$261,780
$15.0 P/Share
|
|
Nov 03
2021
|
Robert E Farrell Jr SVP Finance and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+33.33%
|
$40,000
$4.32 P/Share
|
|
Nov 02
2021
|
Marc Schegerin CFO and COO |
SELL
Exercise of conversion of derivative security
|
Direct |
6,666
-33.57%
|
$99,990
$15.0 P/Share
|
|
Nov 01
2021
|
Marc Schegerin CFO and COO |
SELL
Open market or private sale
|
Direct |
5,477
-45.63%
|
$328,620
$60.0 P/Share
|
|
Nov 01
2021
|
Marc Schegerin CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,477
+31.33%
|
$82,155
$15.0 P/Share
|
|
Oct 26
2021
|
Marc Schegerin CFO and COO |
SELL
Open market or private sale
|
Direct |
37
-0.56%
|
$2,220
$60.0 P/Share
|
|
Oct 26
2021
|
Marc Schegerin CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
37
+0.56%
|
$555
$15.0 P/Share
|
|
Oct 19
2021
|
Bruce Rogers PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+11.22%
|
$52,000
$4.32 P/Share
|
|
Oct 15
2021
|
Marc Schegerin CFO and COO |
SELL
Open market or private sale
|
Direct |
3,338
-33.84%
|
$200,280
$60.0 P/Share
|
|
Oct 15
2021
|
Marc Schegerin CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,338
+25.28%
|
$50,070
$15.0 P/Share
|
|
Oct 14
2021
|
Marc Schegerin CFO and COO |
SELL
Open market or private sale
|
Direct |
24,184
-78.75%
|
$1,451,040
$60.02 P/Share
|
|
Oct 14
2021
|
Marc Schegerin CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,184
+44.06%
|
$362,760
$15.0 P/Share
|
|
Oct 13
2021
|
Marc Schegerin CFO and COO |
SELL
Open market or private sale
|
Direct |
1,964
-23.13%
|
$117,840
$60.0 P/Share
|
|
Oct 13
2021
|
Marc Schegerin CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,964
+18.79%
|
$29,460
$15.0 P/Share
|
|
Sep 16
2021
|
Peter Linde Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-9.16%
|
$260,000
$65.92 P/Share
|
|
Sep 16
2021
|
Peter Linde Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,378
+40.46%
|
-
|
|
Sep 13
2021
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
3,049
-23.37%
|
$198,185
$65.01 P/Share
|
|
Sep 13
2021
|
Bruce Rogers PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,721
-1.88%
|
$111,865
$65.0 P/Share
|
|
Sep 13
2021
|
Bruce Rogers PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,721
+1.84%
|
$6,884
$4.32 P/Share
|
|
Sep 10
2021
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
9,859
-43.04%
|
$640,835
$65.14 P/Share
|
|
Sep 10
2021
|
Robert E Farrell Jr SVP Finance and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,974
+17.84%
|
$19,896
$4.32 P/Share
|
|
Sep 10
2021
|
Bruce Rogers PRESIDENT |
SELL
Open market or private sale
|
Direct |
8,279
-8.43%
|
$538,135
$65.11 P/Share
|
|
Sep 10
2021
|
Bruce Rogers PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
8,279
+7.78%
|
$33,116
$4.32 P/Share
|
|
Sep 09
2021
|
Bruce Rogers PRESIDENT |
SELL
Open market or private sale
|
Direct |
30,000
-8.85%
|
$1,800,000
$60.82 P/Share
|
|
Sep 09
2021
|
Bruce Rogers PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+20.01%
|
$120,000
$4.32 P/Share
|
|
Aug 20
2021
|
Timothy A Springer |
BUY
Open market or private purchase
|
Indirect |
11,620
+0.63%
|
$650,720
$56.4 P/Share
|
|
Aug 19
2021
|
Timothy A Springer |
BUY
Open market or private purchase
|
Indirect |
33,000
+1.21%
|
$1,815,000
$55.95 P/Share
|
|
Aug 18
2021
|
Timothy A Springer |
BUY
Open market or private purchase
|
Indirect |
30,307
+1.72%
|
$1,666,885
$55.88 P/Share
|
|
Jun 18
2021
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
200
-1.1%
|
$13,000
$65.0 P/Share
|
|
Jun 18
2021
|
Robert E Farrell Jr SVP Finance and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+1.09%
|
$800
$4.32 P/Share
|
|
Jun 16
2021
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
300
-1.65%
|
$19,500
$65.0 P/Share
|
|
Jun 16
2021
|
Robert E Farrell Jr SVP Finance and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+1.62%
|
$1,200
$4.32 P/Share
|
|
Jun 14
2021
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
3,526
-16.43%
|
$229,190
$65.0 P/Share
|
|
Jun 14
2021
|
Robert E Farrell Jr SVP Finance and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,526
+14.11%
|
$14,104
$4.32 P/Share
|
|
Jun 10
2021
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
16,000
-47.15%
|
$960,000
$60.08 P/Share
|
|
Jun 10
2021
|
Robert E Farrell Jr SVP Finance and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+32.04%
|
$64,000
$4.32 P/Share
|
|
Jun 01
2021
|
Peter Linde Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,000
-33.28%
|
$300,000
$50.01 P/Share
|
|
May 26
2021
|
Timothy A Springer |
BUY
Open market or private purchase
|
Indirect |
25,000
+1.46%
|
$1,175,000
$47.15 P/Share
|
|
May 25
2021
|
Timothy A Springer |
BUY
Open market or private purchase
|
Indirect |
65,000
+3.8%
|
$2,925,000
$45.97 P/Share
|
|
May 24
2021
|
Timothy A Springer |
BUY
Open market or private purchase
|
Indirect |
40,000
+1.76%
|
$1,840,000
$46.36 P/Share
|
|
May 21
2021
|
Timothy A Springer |
BUY
Open market or private purchase
|
Indirect |
232,295
+24.72%
|
$10,453,275
$45.5 P/Share
|
|
May 21
2021
|
Amir Nashat |
SELL
Open market or private sale
|
Indirect |
232,295
-10.0%
|
$10,453,275
$45.5 P/Share
|
|
Apr 30
2021
|
Omega Fund V, L.P. Director |
SELL
Open market or private sale
|
Direct |
9,487
-0.15%
|
$521,785
$55.01 P/Share
|
|
Apr 29
2021
|
Omega Fund V, L.P. Director |
SELL
Open market or private sale
|
Direct |
7,671
-0.12%
|
$414,234
$54.37 P/Share
|
|
Apr 28
2021
|
Omega Fund V, L.P. Director |
SELL
Open market or private sale
|
Direct |
3,366
-0.08%
|
$185,130
$55.66 P/Share
|
|
Apr 27
2021
|
Omega Fund V, L.P. Director |
SELL
Open market or private sale
|
Direct |
7,338
-0.12%
|
$403,590
$55.5 P/Share
|
|
Apr 26
2021
|
Omega Fund V, L.P. Director |
SELL
Open market or private sale
|
Direct |
5,146
-0.08%
|
$288,176
$56.51 P/Share
|